Because mesothelioma takes decades to develop and commonly affects men who worked heavily around asbestos, it is relatively rare for young individuals, particularly women, to get it.
MCA Staff Writers
Presenting Up-to-Date Mesothelioma Topics
As is the case with any type of cancer, the earlier it’s caught, the better the prognosis will be. What makes mesothelioma such a difficult cancer to beat is, in part, its latency period, which can be anywhere from 20 to 50 years, making it difficult to successfully diagnose and treat the disease early on. Not only do early symptoms not arise until the cancer’s later stages, but they are also easily mistaken with those of common, minor illnesses. Most patients aren’t diagnosed until stage III or IV. So, how can individuals increase their chances of diagnosing this deadly disease as early as possible?
For a newly diagnosed mesothelioma patient, the flood of disease and treatment information that follows can be difficult to process. While you can trust that your doctor will have your best interests in mind when developing your treatment plan, it’s still a good idea to be an active patient and understand the standards of care for mesothelioma.
The conversation around defining survivorship is one with an extensive history rooted alongside the evolution of medicine, research, and culture. According to the American Society of Clinical Oncology (ASCO), over the past 30 or so years, major developments in cancer identification and treatment have contributed to the dramatic increase in cancer survival rates, with the number of cancer survivors estimated to reach 18.1 million in the United States by 2020. But what does this statistic mean when it says “cancer survivors?”
June is Men’s Health Month, a month-long observation and awareness campaign of the issues related to health in men of every age, genetic disposition, and background. Given that men are much less likely to get regular medical checkups than women, it’s important for everyone to be involved with educating the men in their lives about the health issues that can affect them.
Immunotherapy is a form of cancer treatment that uses a patient’s immune system to fight the disease. By manipulating the immune system as a whole or by utilizing components of the immune system, or cell proteins known as antibodies, doctors are able to target additional proteins that help cancer cells grow. The antibodies will bind to the targeted cancer cell proteins and will either stop the cancer cells from growing or will kill them.
A current concern for physicians looking to improve cancer treatment is the need for better methods for monitoring the development of malignant tissues and tumors. This would help physicians be able to personalize treatment for patients on an individual level. As Dr. Heitzer of the Institute of Human Genetics in Graz, Austria states, “methods are needed for a rapid, cost-effective, and noninvasive identification of biomarkers at various time points during the course of [cancer] disease.”1
HIPPA stands for the Health Insurance Portability and Accountability Act and became law in 1996. This law protects your health information that is directly linked to you by your name, address, social security number, insurance identification number, etc. It gave physicians, hospitals, nurses and healthcare practitioners time to comply with the law.